Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
Choosing optimal anti-seizure medication (ASM) is very important in pediatric patients with epilepsy who attend school, especially children with an intellectual disability (ID). Levetiracetam (LEV) has proven to be an effective, safe, generally well-tolerated, broad-spectrum ASM in children. In the...
Guardado en:
Autores principales: | Ja Un Moon, Ji Yoon Han |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac13ae2b7de64dbb9dca02988a2316ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
por: Yi ZM, et al.
Publicado: (2018) -
Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis
por: Meng-Yuan Qiao, et al.
Publicado: (2021) -
Response to Levetiracetam Treatment and Long-Term Follow-Up in Dogs With Reactive Seizures Due to Probable Exogenous Toxicity
por: Fabio Stabile, et al.
Publicado: (2021) -
Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
por: El Sabaa RM, et al.
Publicado: (2020) -
Intellectual and developmental disabilities publication of the American Association on Intellectual and Developmental Disabilities.
Publicado: (2007)